title: Haemodynamic effects of ATP in dogs during hypoxia-induced pulmonary hypertension.
abstract: Pulmonary hypertension may result from an increase in vascular resistance caused by persistent hypoxia. We have investigated the effects of adenosine triphosphate (ATP), administered into the pulmonary artery, on haemodynamic changes occurring in anaesthetized adult dogs subjected to acute hypoxic pulmonary vasoconstriction. Hypoxia alone (ventilation with 10% O2/90% N2) caused significant increases in mean pulmonary arterial blood pressure (PAP), central venous pressure (CVP), and cardiac index (CI) by 71, 102 and 38%, respectively. ATP (0.03-3.0 micromol/kg/min approximately 0.02-1.65 mg/kg/min), when infused under hypoxic conditions, significantly reduced both mean PAP and systemic arterial blood pressure (ABP) in a dose-dependent manner. The maximum decrease in mean PAP amounted to 20%; mean ABP, on the other hand, was decreased by up to 52% (P<0.01). Heart rate, CI, CVP and pulmonary occlusion pressure were not dose-dependently affected by ATP. Our data indicate that while pulmonary arterial administration of ATP in mature dogs during hypoxic pulmonary hypertension causes dilation in the pulmonary vascular bed, it is even more effective in dilating the systemic vasculature. This result suggests a need for further evaluation and warrants cautious use of ATP in the treatment of hypoxic pulmonary hypertension in adult dogs.
authors.affiliation: Veterinary Medical Teaching Hospital, University of California, Davis 95616, USA. bbdriessen@ucdavis.edu
authors.forename: B
authors.initials: B
authors.lastname: Driessen
authors.forename: S C
authors.initials: SC
authors.lastname: Haskins
authors.forename: P J
authors.initials: PJ
authors.lastname: Pascoe
authors.forename: L D
authors.initials: LD
authors.lastname: Tripp
authors.forename: J A
authors.initials: JA
authors.lastname: Reitan
mesh_terms: D000255:Adenosine Triphosphate / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D000818:Animals; D002404:Catheterization / Q000662:veterinary; D004283:Dog Diseases / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D006439:Hemodynamics / Q000187:drug effects*; D006976:Hypertension, Pulmonary / Q000209:etiology / Q000503:physiopathology / Q000662:veterinary*; D000860:Hypoxia / Q000150:complications / Q000503:physiopathology / Q000662:veterinary*
chemical_list: D000255:Adenosine Triphosphate